Gamers at risk of irreversible hearing loss and tinnitus, study suggests
A new review of available evidence suggests video gamers regularly exceed safe sound limits.
Similar Posts
Covid and flu winter jabs to be brought forward in England
As in previous years, the NHS will let people know when bookings open. Adult flu and COVID-19 appointments will be available through the NHS App and website, or by calling 119 for those who can’t get online. Flu vaccines will also be available through local GP practices and pharmacies. Flu vaccinations for children which will…
What to do if you have Covid: Symptoms, tests and can you go to work or school?
Image source, Getty Images The latest Covid booster campaign is under way across the UK and those who qualify are urged to get jabbed as soon as possible. No Covid restrictions are in place across the UK, but guidance recommends people who catch the virus “should try to stay at home”. What are the Covid…
Ozempic and Wegovy overdose calls have spiked, experts say — what to know about dangerous doses
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
What we know about the Covid variant EG.5 dubbed 'Eris'
The World Health Organisation declared the variant of interest, with cases reported in 51 countries.
Theresa May's type 1 diabetes go-to was Jelly Babies
The former prime minister tells BBC News sweets helped her out in some sticky situations in meetings.
Bristol Myers Squibb to buy Karuna Therapeutics
Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share. Karuna’s stock closed up more than 47% on the news Friday, hitting $317.85 a share. Bristol Myers Squibb shares closed up 2%. The deal will help expand Bristol Myers’ drug pipeline after…